Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.3852
-0.0047 (-1.21%)
Apr 25, 2025, 12:41 PM EDT - Market open
Harvard Bioscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 4.11 | 4.28 | 4.51 | 7.82 | 8.32 | Upgrade
|
| Cash & Short-Term Investments | 4.11 | 4.28 | 4.51 | 7.82 | 8.32 | Upgrade
|
| Cash Growth | -4.09% | -4.99% | -42.36% | -5.96% | -0.22% | Upgrade
|
| Accounts Receivable | 14.87 | 16.1 | 16.71 | 21.83 | 17.77 | Upgrade
|
| Receivables | 14.87 | 16.1 | 16.71 | 21.83 | 17.77 | Upgrade
|
| Inventory | 23.25 | 24.72 | 26.44 | 27.59 | 22.26 | Upgrade
|
| Other Current Assets | 2.9 | 3.94 | 3.47 | 4.34 | 3.36 | Upgrade
|
| Total Current Assets | 45.12 | 49.04 | 51.12 | 61.58 | 51.7 | Upgrade
|
| Property, Plant & Equipment | 11.24 | 8.75 | 9.18 | 10.31 | 11.72 | Upgrade
|
| Long-Term Investments | - | 3.5 | - | - | - | Upgrade
|
| Goodwill | 56.32 | 57.07 | 56.26 | 57.69 | 58.59 | Upgrade
|
| Other Intangible Assets | 11.13 | 16.04 | 21.01 | 27.39 | 33.15 | Upgrade
|
| Long-Term Deferred Tax Assets | 0.09 | 0.44 | 0.33 | 0.21 | 0.26 | Upgrade
|
| Other Long-Term Assets | 2.74 | 2.54 | 7.45 | 5.17 | 0.84 | Upgrade
|
| Total Assets | 126.64 | 137.37 | 145.36 | 162.34 | 156.25 | Upgrade
|
| Accounts Payable | 4.79 | 5.55 | 6.45 | 4.91 | 5.97 | Upgrade
|
| Accrued Expenses | 2.26 | 4.43 | 3.87 | 6.53 | 4.15 | Upgrade
|
| Current Portion of Long-Term Debt | 36.96 | 5.86 | 3.81 | 3.24 | 1.72 | Upgrade
|
| Current Portion of Leases | 1.16 | 1.42 | 2.14 | 2.14 | 2.11 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 0.22 | 0.29 | Upgrade
|
| Current Unearned Revenue | 3.81 | 4.51 | 3.37 | 4.27 | 3.77 | Upgrade
|
| Other Current Liabilities | 5.99 | 4.78 | 3.62 | 4.01 | 3.05 | Upgrade
|
| Total Current Liabilities | 54.96 | 26.54 | 23.25 | 25.32 | 21.05 | Upgrade
|
| Long-Term Debt | - | 30.9 | 43.01 | 45.1 | 46.29 | Upgrade
|
| Long-Term Leases | 6.38 | 4.79 | 5.28 | 6.49 | 7.48 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.71 | 0.78 | 0.59 | 1.56 | 1.9 | Upgrade
|
| Other Long-Term Liabilities | 1.26 | 1.28 | 1.01 | 0.49 | 1.26 | Upgrade
|
| Total Liabilities | 63.3 | 64.29 | 73.14 | 78.94 | 79.57 | Upgrade
|
| Common Stock | 0.44 | 0.43 | 0.45 | 0.45 | 0.44 | Upgrade
|
| Additional Paid-In Capital | 236.58 | 232.44 | 229.01 | 225.65 | 232.36 | Upgrade
|
| Retained Earnings | -158.01 | -145.61 | -142.19 | -132.67 | -132.39 | Upgrade
|
| Treasury Stock | - | - | - | - | -10.67 | Upgrade
|
| Comprehensive Income & Other | -15.67 | -14.19 | -15.05 | -10.03 | -13.07 | Upgrade
|
| Shareholders' Equity | 63.34 | 73.07 | 72.22 | 83.4 | 76.68 | Upgrade
|
| Total Liabilities & Equity | 126.64 | 137.37 | 145.36 | 162.34 | 156.25 | Upgrade
|
| Total Debt | 44.5 | 42.97 | 54.24 | 56.96 | 57.6 | Upgrade
|
| Net Cash (Debt) | -40.39 | -35.19 | -49.73 | -49.14 | -49.28 | Upgrade
|
| Net Cash Per Share | -0.93 | -0.83 | -1.20 | -1.22 | -1.28 | Upgrade
|
| Filing Date Shares Outstanding | 44.07 | 43.4 | 42.19 | 41.23 | 39.83 | Upgrade
|
| Total Common Shares Outstanding | 44.07 | 43.39 | 42.08 | 41.14 | 39.41 | Upgrade
|
| Working Capital | -9.84 | 22.5 | 27.88 | 36.27 | 30.65 | Upgrade
|
| Book Value Per Share | 1.44 | 1.68 | 1.72 | 2.03 | 1.95 | Upgrade
|
| Tangible Book Value | -4.12 | -0.03 | -5.05 | -1.67 | -15.06 | Upgrade
|
| Tangible Book Value Per Share | -0.09 | -0.00 | -0.12 | -0.04 | -0.38 | Upgrade
|
| Machinery | 18.36 | 15.95 | 15.71 | 15.3 | 18.02 | Upgrade
|
| Leasehold Improvements | 2.57 | 2.42 | 2.51 | 2.56 | 2.54 | Upgrade
|
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.